Bruker (NASDAQ:BRKR – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.79-2.84 for the period, compared to the consensus estimate of $2.71. The company issued revenue guidance of $3.29-3.35 billion, compared to the consensus revenue estimate of $3.28 billion. Wall […]
Bruker (NASDAQ:BRKR – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $2.79-2.84 for the period, compared to the consensus EPS estimate of $2.71. The company issued revenue guidance of $3.29-3.35 billion, compared to the consensus revenue estimate of $3.28 billion. Bruker Trading Down 0.1 % Bruker stock […]
Bruker (NASDAQ:BRKR – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.07, Briefing.com reports. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The firm had revenue of $721.70 […]
Buckhead Capital Management LLC purchased a new position in shares of Bruker Co. (NASDAQ:BRKR – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 22,244 shares of the medical research company’s stock, valued at approximately $1,634,000. Several other institutional investors have also bought and sold shares of the stock. Lindbrook Capital […]
Shares of Bruker Co. (NASDAQ:BRKR – Get Free Report) have been given an average recommendation of “Hold” by the seven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. […]